Gelmap. Spot visualization by LUH

Peptidelist

IDFDRAccessionNameRank Pep_isbold Pep_isuniquePep_exp_mzPep_exp_mrPep_exp_zPep_calc_mrPep_deltaPep_missPep_scorePep_seqPep_var_modPep_var_mod_posTypePep_scan_title
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111454.2407906.46692906.4810-0.0142032.84YLIENGAKCID Cmpd 46, +MSn(454.2407), 12.5 min
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111500.2953998.57612998.5913-0.0152039.37FSLAPLVPRCID Cmpd 233, +MSn(500.2953), 19.9 min
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111546.78171091.548921091.5611-0.0122083.09FAAGTEAIANKCID Cmpd 49, +MSn(546.7817), 12.6 min
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111550.82681099.639121099.6488-0.0097033.31IGVIESLLEKCID Cmpd 240, +MSn(550.8268), 20.6 min
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111553.28651104.558521104.5663-0.0078072.19SVGDLTSADLKCID Cmpd 112, +MSn(553.2866), 14.8 min
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111702.86781403.721121403.7296-0.0085079.20ELDYLVGAVSNPKCID Cmpd 201, +MSn(702.8679), 18.1 min
95<0.01AT3G12780.1Phosphoglycerate kinase 1, PGK1111645.32691932.958731932.9694-0.0106052.40LASLADLYVNDAFGTAHRCID Cmpd 239, +MSn(645.3268), 20.5 min
95<0.01ATCG00020.1PsbA, D1111744.4219743.41461743.4177-0.0031029.51TAILERAcetyl (N-term)1.000000.0CID Cmpd 181, +MSn(744.4219), 17.1 min
95<0.01ATCG00020.1PsbA, D1111450.7595899.50452899.5188-0.0143143.42TAILERRAcetyl (N-term)1.0000000.0CID Cmpd 131, +MSn(450.7596), 15.4 min
95<0.01ATCG00020.1PsbA, D1111482.2245962.43442962.4457-0.0113044.85ESESLWGRCID Cmpd 123, +MSn(482.2245), 15.2 min
95<0.01ATCG00020.1PsbA, D1111657.85741313.700221313.7092-0.0090098.81VINTWADIINRCID Cmpd 230, +MSn(657.8574), 19.8 min
95<0.01ATCG00020.1PsbA, D1111750.31041498.606221498.6172-0.0109083.56ETTENESANEGYRCID Cmpd 2, +MSn(750.3104), 9.7 min
95<0.01ATCG00020.1PsbA, D1111440.19481317.562431317.5805-0.0181034.17ANLGMEVMHER2 Oxidation (M)0.00002002000.0CID Cmpd 10, +MSn(440.1948), 10.8 min
95<0.01AT5G01530.1Lhcb4.1, CP29111508.27401014.533521014.5458-0.0123045.86NLAGDVIGTRCID Cmpd 127, +MSn(508.2740), 15.3 min
95<0.01AT5G01530.1Lhcb4.1, CP29111557.82191113.629121113.6393-0.0102028.78TAQLQLAEIKCID Cmpd 157, +MSn(557.8218), 16.3 min
95<0.01AT5G01530.1Lhcb4.1, CP29111710.35641418.698121418.7082-0.0100053.40FFDPLGLAADPEKCID Cmpd 248, +MSn(710.3563), 21.4 min
95<0.01AT5G01530.1Lhcb4.1, CP29111878.43581754.857121754.8628-0.0057039.49STPFQPYSEVFGIQRCID Cmpd 238, +MSn(878.4359), 20.5 min
95<0.01AT5G01530.1Lhcb4.1, CP29111567.95951700.856831700.8693-0.0125124.22NLAGDVIGTRTEAADAKCID Cmpd 111, +MSn(567.9595), 14.8 min
95<0.01AT2G39730.1RCA, rubisco activase (Gene model 1)111504.26821006.521821006.5335-0.0117044.62FVESLGVEKCID Cmpd 108, +MSn(504.2682), 14.7 min
95<0.01AT2G39730.1RCA, rubisco activase (Gene model 1)111530.30721058.599921058.6124-0.0125026.67NFLTLPNIKCID Cmpd 235, +MSn(530.3073), 19.9 min
95<0.01AT2G39730.1RCA, rubisco activase (Gene model 1)111576.85581151.697021151.7067-0.0097065.03VPLILGIWGGKCID Cmpd 253, +MSn(576.8558), 22.8 min
95<0.01AT2G39730.1RCA, rubisco activase (Gene model 1)111614.78201227.549421227.5628-0.0134047.52SFQCELVMAKOxidation (M)0.0000000200.0CID Cmpd 126, +MSn(614.7820), 15.3 min
95<0.01AT2G39730.2RCA, rubisco activase (Gene model 2)101504.26821006.521821006.5335-0.0117044.62FVESLGVEKCID Cmpd 108, +MSn(504.2682), 14.7 min
95<0.01AT2G39730.2RCA, rubisco activase (Gene model 2)101530.30721058.599921058.6124-0.0125026.67NFLTLPNIKCID Cmpd 235, +MSn(530.3073), 19.9 min
95<0.01AT2G39730.2RCA, rubisco activase (Gene model 2)101576.85581151.697021151.7067-0.0097065.03VPLILGIWGGKCID Cmpd 253, +MSn(576.8558), 22.8 min
95<0.01AT2G39730.2RCA, rubisco activase (Gene model 2)101614.78201227.549421227.5628-0.0134047.52SFQCELVMAKOxidation (M)0.0000000200.0CID Cmpd 126, +MSn(614.7820), 15.3 min
95<0.01AT2G39730.3RCA, rubisco activase (Gene model 3)101504.26821006.521821006.5335-0.0117044.62FVESLGVEKCID Cmpd 108, +MSn(504.2682), 14.7 min
95<0.01AT2G39730.3RCA, rubisco activase (Gene model 3)101530.30721058.599921058.6124-0.0125026.67NFLTLPNIKCID Cmpd 235, +MSn(530.3073), 19.9 min
95<0.01AT2G39730.3RCA, rubisco activase (Gene model 3)101576.85581151.697021151.7067-0.0097065.03VPLILGIWGGKCID Cmpd 253, +MSn(576.8558), 22.8 min
95<0.01AT2G39730.3RCA, rubisco activase (Gene model 3)101614.78201227.549421227.5628-0.0134047.52SFQCELVMAKOxidation (M)0.0000000200.0CID Cmpd 126, +MSn(614.7820), 15.3 min
95<0.01AT3G08940.2Lhcb4.2, CP29 (Gene model 2)101878.43581754.857121754.8628-0.0057039.49STPFQPYSEVFGLQRCID Cmpd 238, +MSn(878.4359), 20.5 min
95<0.01AT3G08940.2Lhcb4.2, CP29 (Gene model 2)111507.29831012.582021012.5917-0.0096029.81AQLQLAEIKCID Cmpd 150, +MSn(507.2983), 16.1 min
95<0.01AT3G08940.2Lhcb4.2, CP29 (Gene model 2)111561.29641120.578221120.5877-0.0094029.47NLYGEVIGTRCID Cmpd 175, +MSn(561.2964), 16.9 min
95<0.01AT3G08940.2Lhcb4.2, CP29 (Gene model 2)111511.94371532.809431532.8239-0.0145152.21FFDPLGLASDPVKKCID Cmpd 232, +MSn(511.9437), 19.8 min
95<0.01AT3G08940.2Lhcb4.2, CP29 (Gene model 2)111529.62151585.842731585.8617-0.0190016.34TVISDRPLWFPGAKCID Cmpd 209, +MSn(529.6215), 18.6 min
95<0.01AT1G29910.1Lhcb1.2, CAB3, AB180111492.2476982.48072982.4913-0.0106036.36FGEAVWFKCID Cmpd 228, +MSn(492.2476), 19.4 min
95<0.01AT1G29910.1Lhcb1.2, CAB3, AB180111633.27721264.539821264.5473-0.0075061.11GPSGSPWYGSDRCID Cmpd 96, +MSn(633.2772), 14.3 min
95<0.01AT1G29910.1Lhcb1.2, CAB3, AB180111418.22311251.647631251.6683-0.0208131.44NRELEVIHSRCID Cmpd 16, +MSn(418.2231), 11.0 min
95<0.01AT5G35630.1GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo111527.94411580.810531580.8297-0.0192037.97TIEKPVEDPSELPKCID Cmpd 73, +MSn(527.9441), 13.5 min
95<0.01AT5G35630.2GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo101527.94411580.810531580.8297-0.0192037.97TIEKPVEDPSELPKCID Cmpd 73, +MSn(527.9441), 13.5 min
95<0.01AT5G35630.3GS2, GLN2, ATGSL1, glutamine synthetase 2 (Gene mo101527.94411580.810531580.8297-0.0192037.97TIEKPVEDPSELPKCID Cmpd 73, +MSn(527.9441), 13.5 min